home / stock / biovf / biovf news


BIOVF News and Press, Swedish Orphan Biovit Ord From 06/12/19

Stock Information

Company Name: Swedish Orphan Biovit Ord
Stock Symbol: BIOVF
Market: OTC

Menu

BIOVF BIOVF Quote BIOVF Short BIOVF News BIOVF Articles BIOVF Message Board
Get BIOVF Alerts

News, Short Squeeze, Breakout and More Instantly...

BIOVF - Sobi Acquires Emapalumab and Related Assets

STOCKHOLM , June 12, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI)   has signed an agreement to acquire, from Novimmune's shareholders, a newly established company owning emapalumab and related assets, giving Sobi access to world-class R&D ca...

BIOVF - Sobi(TM) Appoints Amy Pott as New Head of Sobi North America

STOCKHOLM , April 30, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Amy Pott as the new Head of Sobi North America . She takes over effective today, replacing Rami Levin who is leaving Sobi. " Sobi North America is entering a new phase in l...

BIOVF - Swedish Orphan Biovitrum AB (BIOVF) CEO Guido Oelkers on Q1 2019 Results - Earnings Call Transcript

Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2019 Earnings Conference Call April 25, 2019 4:00 AM ET Company Participants Guido Oelkers – Chief Executive Officer Henrik Stenqvist – Chief Finanical Officer Milan Zdravkovic – Chief Scientific Officer Confer...

BIOVF - Swedish Orphan Biovitrum AB (publ) 2019 Q1 - Results - Earnings Call Slides

The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2019 Q1 earnings Read more ...

BIOVF - Swedish Orphan Biovitrum AB (publ) reports Q1 results

Swedish Orphan Biovitrum AB (publ) ( OTCPK:BIOVF ): Q1 Non-GAAP EPS of SEK3.03; GAAP EPS of SEK3.14. More news on: Swedish Orphan Biovitrum AB (publ), Earnings news and commentary, Healthcare stocks news, Read more ...

BIOVF - Sobi(TM) Publishes 2018 Annual and Sustainability Report

STOCKHOLM , April 18, 2019 /PRNewswire/ - Swedish Orphan Biovitrum AB (publ) (Sobi™) has released the company's 2018 Annual and Sustainability Report. The integrated report summarises our business and strategy, financial performance and work on sustainability. "2018 was a year ...

BIOVF - Sobi and Novimmune Selected as Honourees for 2019 National Organization for Rare Disorders (NORD) Rare Impact Award in Industry Innovation for Gamifant® (emapalumab)

STOCKHOLM , March 25, 2019 /PRNewswire/ -- Sobi™ and Novimmune SA have both been selected as honourees by the National Organization for Rare Disorders (NORD) for the 2019 Rare Impact Awards. The companies were nominated in the category of Industry Innovation in recognition of the U...

BIOVF - Invitation to Sobi Capital Markets Day 14 May 2019

STOCKHOLM , Feb. 21, 2019 /PRNewswire/ -- Save the date for Swedish Orphan Biovitrum AB (publ) (Sobi™) Capital Markets Day on 14 May 2019 . The event will take place at Karolinska Institutet Biomedicum, Solnavägen 9, Solna, from 12:30 – 16:30. A lighter lunch will be...

BIOVF - Swedish Orphan Biovitrum AB 2018 Q4 - Results - Earnings Call Slides

The following slide deck was published by Swedish Orphan Biovitrum AB in conjunction with their 2018 Q4 earnings Read more ...

BIOVF - Swedish Orphan Biovitrum AB reports Q4 results

Swedish Orphan Biovitrum AB ( OTCPK:BIOVF ): Q4 GAAP EPS of SEK2.20. More news on: Swedish Orphan Biovitrum AB, Earnings news and commentary, Healthcare stocks news, Read more ...

Previous 10 Next 10